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The lipid composition of 17 xanthomatous lesions from 
16 patients with different types of hyperlipoproteinae-
mia was analyzed. The relative amounts of free choles-
terol, cholesterolesters, and phospholipids in xanthomas 
obtained from patients who s ubsequently showed 
regression of their remaining type of xanthomas were 
different in comparison with xanthomas which did not 
show regression. One tendinous xanthoma contained 
more than 50% free cholesterol and resembled in lipid 
cOIIlposition the gruel plaques found in atherosclerotic 
lesions. The relative amounts of free cholesterol, choles-
terolesters, and phospholipids in regressing xanthomas 
were similar to those of fatty streaks found in arteries of 
children between the ages of 5-10 yr. Histochemical 
studies using an enzymatic method d emonstrated that 
free and esterified cholesterol were located in focal areas 
of xanthomatou s tissue. It i s concluded that the physical 
state of lipids in xanthomatous lesions can vary remark-
ably and plays an important role with regard to the 
possibility of regression. 
Xanthomatous lesions can be found in patients with elevated 
or with normal lipoprotein levels [1,2,3, review 1 and 4). 
With the exception of tendinous xanthomas, the other xan-
thomas are histologically characterized by cholesterolester ac-
cumulation in dermal foam cells [5,6]. Accumulated cholester-
olester persists in most types of xanthomas (e.g., xanthelasma 
palpebrarum, xanthoma planum, tendinous xanthoma). How-
ever, t h e accumulated lipids can easily disappear from eruptive 
xanthomas once elevated serum lipoprotein levels have been 
lowered [7-10). Ultrastructural studies h ave shown that most 
of the accumulated lipids in eruptive xanthomas as well as in 
xanthelasma and xanthoma planum are intracellularly localized 
[11-13]. Moreover, biochemical analyses of tendinous and erup-
tive xanthomas favored the hypothesis that free cholesterol 
becomes esterified in both lesions and that during the aging 
process triglycerides are predominantly degraded in eruptive 
xanthomas [14,15). 
This investigation was performed in order to see if the val'iolls 
types of xanthomatous lesions differ in lipid composition and in 
the localization of free cholesterol and cholesterolesters. 
PATIENTS AND METHODS 
Patie nts 
Seventeen xanthomatous lesions were obtained from 16 patients. 
The lipoprotein abnormalities found in the sera of these patients are 
shown in Table 1. 
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From one patient 2 xanthelasmas were obtained. Blood sampling 
and lipid and lipoprotein analyses of the fasting serum was canied out 
as described [2). 
From 9 patients the xanthomatous lesions were removed when no 
treatment was given. The remaining 7 patients were on treatment for 
more than 6 mo when the tissue was obtained for lipid analysis (see 
also Table II). 
The treatment for those patients with elevated LDL levels consisted 
of a low cholesterol. low sat.urated fa t diet with or without the addition 
of Questran. The patients with elevated VLDL or IDL levels received 
a low carbohydrate diet and in case the patients were obese the diet 
was also hypocaloric. 
All patients were fo llowed up for more than 1 yr t.o establish the 
effect of the treatment schedules on the remaining xanthomatous 
lesions. 
METHODS 
Biochemica.l Ana.lysis of Shin Specim.ens 
Xanthomas were obtained by excision or punch biopsy under local 
anesthesia and freed of adipose tissue. The specimens were then divided 
into 2 equal parts. One pru·t was deep-frozen and stored at -20°C for 
biochemical analysis. The other part was fixed in 4% p-formaldehyde 
in 0.1 M phosphate buffer (pH 7.4). 
The lipids were extracted from minced xanthomas with methanol: 
ch loroform (1:2 v I v) according to Folch et aI [18). After evaporation of 
the solvent, the lipids were redissolved in 1 ml chloroform. An aliquot 
was taken for gravimetric determination of total lipids. The lipids were 
sepru'ated by chromatography on thin layers of silicagel and the lipid 
composition was determined densitometrically after charring with sul-
furic acid [19). 
Histochemica.l Analysis 
Frozen serial sections (14 /.un thick) were cut from uneI1lbedded fixed 
tissue, collected in 0.1 M phosphate buffer (pH 7.4) and washed for 30 
min at room temperatul'e to remove any residual fixative. Free and 
esterified cholesterol were visualized as described in detail elsewhere 
[20). In brief, the staining method is based on oxidat.ion of free choles-
terol by cholesterol oxidase leading to the release of H20 ,. Sites where 
H,0 2 is produced are visualized by reacting the H20 , with 3-
3'diaminobenzidine in a peroxidase catalyzed reaction, which procedure 
resul ts in the production of a brown insoluble polymer. 
Esterified cholesterol can be demonstrated after a preincubation step 
using cholesterol esterase. Other sections of the xanthomatous tissues 
were stained with haematoxylin-eosin and with Oil Red O. 
RESULTS 
Lipid Analysis 
The results of the lipid analysis, arranged according to cho-
Ie sterol ester content as a percentage of total lipids, are shown 
in Table II. It can be seen that all nine xanthomas obtained 
from patients who subsequently showed regression had a cho-
lesterolester content of below 35%, and a phospholipid content 
of more than 25%. In 4 of these 9 xanthomas the triglyceride 
content was. higher than 30%, whereas this relative amount of 
triglyceride was also found in 2 out of 8 xanthomas without 
regression. The only xanthoma with a cholesterol ester content 
below 35% which did not show regression, was a tendinous 
xanthoma which contained an exceptionally high level of free 
cholesterol. All xanthomatous lesions 9/ 17 which showed 
regression, were present on patients with eleva ted VLDL or 
IDL levels. No differences in lipid analysis could be observed 
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TABLE 1. The distribution of various types of xanthoma tOllS lesions 
Type of lesion No. of patients 
Elevated" 
LDL 
Elevated" 
VLDL 
Elevated VLDL" (lDL present) Normoiipaenlic 
Papu lo eruptive xanthoma 5 1 4 
Tubero eruptive xanthoma 5 2 3 
Xanthelasma 1 2+<1 
Tendinous xanthoma 1 1 
Xanthoma planum 2 2 
Tuberous xanthoma 2 1 
" LDL = Low Density Lipoprotein; 1.006 < d < 1.063, elevated = total lipid LDL > 550 mgldl serum [17] comparable with hyperlipoproteinaemia 
type lIlA (WHO) [15]. 
b VLDL = Very Low Density Lipoprotein; 0.94 < d < 1.006, elevated = total lipid VLDL > 260 mg/ dl serum [17] comparable with 
hyperlipoproteinaemia type IV IV (WHO). 
,. IDL = Intermediate Density Lipoprotein, present when the cholesterol/triglyceride ratio in VLDL = >0.5 [10]; VLDL elevated; compamble 
with hyperlipoproteinaemia type III (WHO). 
" + = From one patient 2 xanthomas were removed and studied. 
TABLE II. Xanthomas arranged according to relative amount of cholesterolester" 
Lipoprotein Therapy at Therapy 1 yr Patients Type xanthoma Regression As % of tota l lipids remova l xan-elevated Lhoma after rell10va l 
TC FC CE PL TG FFA 
1 Planum N 51 09 72 01 13 05 
2 Tuberous LDL 51 13 64 16 02 05 Diet Diet 
3a Xanthelasma N 45 10 60 14 14 02 
3b Xanthelasma N 44 10 57 16 14 03 
4 Tuberous LDL 43 10 56 17 13 04 Diet + Q Diet + Q 
5 Papulo-eruptive LDL 34 07 45 13 33 02 Diet Diet 
6 Planum N 29 06 39 12 40 03 
7 Tubero-eruptive + VLDL 37 18 33 26 21 02 Diet 
8 Tendinous LDL 72 55 28 13 01 03 Diet + Q Diet + Q 
9 Tubero-eruptive + VLDL 34 17 28 32 17 06 Diet 
10 Tubero-eruptive + IDL 32 17 28 31 17 08 Diet 
11 Tubero-eruptive + IDL 34 20 23 45 17 06 Diet 
12 Tubero-eruptive + IDL 35 22 22 38 09 03 Diet Diet 
13 Papulo-eruptive + VLDL 21 11 18 23 37 12 Diet 
14 Papulo-eruptive + VLDL 18 08 17 25 42 08 Diet 
15 Papulo-eruptive + VLDL 20 11 15 30 33 11 Diet Diet 
16 Papulo-eruptive + VLDL 17 10 12 33 32 13 Diet Diet 
" T C = total cholesterol; FC = free cholesterol; CE = cholesterolesters; 1'L = phospholipids; TG = triglyceride; FFA = free fatty acids; N = 
normolipaemic; Q = Questran. Total cholesterol was calculated by the equation % TC = 0.58 X % CE + % FC. 
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FIG 1. Phase diagram of a 3 component system showing interactions 
of cholesterol (8) , phospholipid (PPL) and cholesterol esters (8E) in 
excess water at 37°C . • = xanthomatous lesions without regression; 0 
= xanthomatous lesions with regression. [ represents gruel plaque 
[23]; II represents fatty streak adult (23); TIl represents adrenal glands 
[23J; TV represents normal intima [24]; V represents fatty streak chil-
ill'en [24); VT represents high density lipoprotein (HDL) [25]. The 
tendinous xanthoma at the top of the diagram has an exceptional place 
and corresponds with a lipid composition of S 57%, SE- 39% and PPL 
13%. 
between the [6] removed prior to treatment and those [13] 
removed during a dietary treatment. 
By plotting the relative amounts of cholesterolesters, fi'ee 
cholesterol and phospholipids, a clear delineation of the several 
xanthoma types occurred, as shown in a phase diagram (Fig 1) 
according to Small [21,22]. Those xanthomatous lesions which 
regressed were clearly separated from the nonregressing xan-
thomas. We compared our findings with data on the lipid 
composition of other tissues in which cholesterol or cholester-
olesters accumulate (e.g., atherosclerotic vascular lesions, fatty 
streaks of the vessel wall, adrenal glands) [23]. In this diagram 
data on the lipid composition of a normal intima, of a fatty 
streak in a young child [24] and of HDL [25] are also shown. 
The lipid composition of adult fatty streaks and of the lipid 
core of atherosclerotic lesions [23] resembles the lipid compo-
sition of xanthomatous lesions which do not regress. The lipid 
composition of fatty streaks in young children [24] and of HDL 
[25] resembles the findings in xanthomas whi.ch regress easily. 
Histochemical Observations 
In most xanthomatous lesions discreet deposits of cholester-
olesters could be found. These deposits were mainly present in 
the deeper layers of the dermis and the mid-dermis. Free 
cholesterol could be demonstrated in only 3 lesions which 
contained more than 20% of free cholesterol. In these lesions 
the localization of free cholesterol was distinct from the locali-
zation of cholesterolesters. This is demonstrated in Fig 2 and ,3, 
showing a positive staining for respectively fTee cholesterol and 
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FIG 2 and 3. Serial sections of human tendinous xanthoma stained 
for free (Fig 2) and esterified cholesterol (Fig 3). Note: different areas 
of t h e xanthoma contain free cholesterol or esterified cholesterol. No 
counterstain (reduced from x 150). 
cholesterol esters in different areas of 2 serial sections from a 
tendinous xanthoma. 
DISCUSSION 
The role of lipoproteins for the development and regTession 
of xanthomas has been extensively described during the last 10 
yr [1,2,26-28]. Also in our study, the patients who showed 
regression of xanthomas were characterized by elevated VLDL 
or IDL levels. Biochemical analysis showed that the xanthomas 
which regressed had a lower cholesterol ester and higher phos-
pholipid content in comparison with the xanthomas which did 
not regress (Table II). However, the triglycerides were elevated 
in only 4 of the 9 xanthomas obtained from patients who 
showed a regression of the remaining xanthomas. The lower 
triglyceride content of several xanthomas with regression could 
be explained by the "age" of these lesions [14]. As the xantho-
mas with regression are mainly characterized by a relatively 
low cholesterol ester content and a high phospholipid content 
the interrelationship between these 2 lipids could be crucial for 
the possibility of regression. In the phase·diagram, the interre-
lationship of free cholesterol, phospholipids and cholesteroles-
ters are shown and a further deviation between the different 
groups of xanthomas is obtained (Fig 1). According to the 
physical studies of Small [21] the relative amounts of phospho-
lipids, cholesterolesters, and free cholesterol will determine the 
physical properties of these lipid mixtures. Using the data of 
Small [21,22], the xanthomas which regressed easily are char-
acterized by an abundance of phospholipid-liquid crystalline 
phase and less cholesterolester-Iiquid or liquid-crystalline 
phase. In the other group of xanthomas the physical state of 
the lipids is the reverse. 
The melting point of the cholesterolesters will determine 
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whether these lipids are accumulated in a liquid-crystalline or 
liquid phase. Most cholesterolesters in xanthomatous tissue are 
composed of cholesterol oleate (melting point ± 50°C) [29] and 
it is therefore conceivable that the cholesterolesters are pre-
dominantly accumulated in a liquid-crystalline phase [21). 
The tendinous xanthoma has an exceptional lipid composi-
t ion mainly due to the high amount of free cholesterol. This 
xanthomatous lesion resembles the core of advanced gruel 
plaques and should be characterized by the presence of choles-
terol-monohydrate crystals [30] as confirmed histochemically 
and electronmicroscopically [31]. 
The histochemical observations in the xanthomatous lesions 
show that t he cholesterolesters are mainly accumulated in focal 
areas. These findings are in accordance with the localization of 
foam cells as observed by light- and electron microscopy [5,6]. 
Moreover, the histochemical studies in the tendinous xanthoma 
showed that free cholesterol and cholesterol esters are located 
in different areas. It is therefore understandable that certain 
specimens of tendinous xanthoma might contain excessive 
amounts of free cholesterol whereas other specimens do not 
[14,15]. The biochemical and histoch emical data on the various 
types of xanthomatous lesions all suggest that no regression 
occurs if focal accumulated cholesterolesters are present in a 
liquid-crystalline phase. The same holds true for the accumu-
lated cholesterol crystals in the tendinous xanthomas. However, 
when the xanthomas have a phospholipid-liquid crystalline-like 
phase regression can easily occur. Our study suggests that apart 
from lipoprotein levels also the physical state of the lipids in 
xanthomatous lesions is an important factor with regard to the 
possibility of regression. 
The authors wish to thank W.P. Hillebrands for technical 
assistance and C. Horsting for typing the manuscript. 
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